Estimation of Blood-Brain Barrier Crossing of Drugs Using Molecular Size and Shape, and H-Bonding Descriptors

References

• 4th International Conference on Oral Drug Absorption, Edinburgh, June, 13–151997, Abstracts in Eur. J. Pharm. Sci. 1997, 5 (Suppl. 2), S1-S74
   Google Scholar
• Abraham M. Scales of solute hydrogen-bonding: Their construction and application to physicochemical and biochemical processes. Chem. Soc. Rev 1993; 22: 73–83
   Web of Science ®Google Scholar
• Abraham M. H., Chadha H. S., Mitchell R. C. Hydrogen bonding. Part 33. The factors that influence the distribution of solutes between blood and brain. J. Pharm. Sci 1995a; 84: 1257–1268
   Google Scholar
• Abraham M. H., Chadha H. S., Mitchell R. C. Hydrogen bonding. Part 36. Determination of blood brain distribution using octanol-water partition coefficients. Drug Des. Discov 1995b; 13: 123–131
   PubMedGoogle Scholar
• Abraham M. H., Lieb W. R., Franks N. P. Role of hydrogen bonding in general anesthesia. J. Pharm, Sci 1991; 80: 719–724
   PubMed Web of Science ®Google Scholar
• Abraham M. H., Takacs-Novak K., Mitchell R. C. On the partition of ampholytes: Application to blood-brain distribution. J. Pharm. Sci 1997; 86: 310–315
   PubMed Web of Science ®Google Scholar
• Audus K. L., Chikdale P. J., Miller D. W., Thompson S. E., Borchardt R. T. Brain uptake of drugs: The influence of chemical and biological factors. Adv. Drug Res 1992; 23: 1–64
   Google Scholar
• Barlow D., Satoh T. The design of peptide analogues for improved absorption. J. Contr. Rel 1994; 29: 283–291
   Web of Science ®Google Scholar
• Basak S. C., Gute B. D., Drewes L. R. Predicting blood-brain transport of drugs: a computational approach. Pharm. Res 1996; 13: 775–778
   PubMed Web of Science ®Google Scholar
• Begley D. J. The blood-brain barrier: principles for targeting peptides and drugs to the central nervous system. J. Pharm. Pharmacol 1996; 48: 136–146
   PubMed Web of Science ®Google Scholar
• Bodor N., Gabanyi Z., Wong C. K. A new method for the estimation of partition coefficient. J. Amer. Chem. Soc 1989; 111: 3783–3786
   Web of Science ®Google Scholar
• Bonate P. L. Animal models for studying transport across the blood-brain barrier. J. Neurosci. Meth 1995; 56: 1–15
   PubMed Web of Science ®Google Scholar
• Broadwell R. D. Transcytosis of macromolecules through the blood-brain fluid barriers in vivo. Biological Barriers to Protein Delivery, K. L. Audus, Th. J. Raub. Plenum Press, New York 1993; 269–296
   Google Scholar
• Cai S. X., Kher S. M., Zhou Z. L., Ilyin V., Espitia S. A., Tran M., Hawkinson J. E., Woodward R. M., Weber E., Keana J. F. W. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: Potent and systematically active antagonists for the glycine site of the NMDA receptor. J. Med. Chem 1997; 40: 730–738
   PubMed Web of Science ®Google Scholar
• Calder J. A., Ganellin C. R. Predicting the brain-penetrating capability of histaminergic compounds. Drug Des. Discov 1994; 11: 259–268
   PubMedGoogle Scholar
• Camenisch G., Folkers G., Van de Waterbeemd H. Review of theoretical drug absorption models: Historical background, recent developments and limitations. Pharm. Acta Helv 1996; 71: 309–327
   PubMedGoogle Scholar
• Chikhale E. G., Ng K. Y., Burton Ph. S., Borchardt R. T. Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides. Pharm. Res 1994; 3: 412–419
   Google Scholar
• Conradi R. A., Burton P. S., Borchardt R. T. Physico-chemical and biological factors that influence a drug's cellular permeability by passive diffusion. Lipophilicity in Drug Action and Toxicology, V. Pliska, B. Testa, H. Van de Waterbeemd. VCH, Weinheim 1996; 233–252
   Google Scholar
• Desai M. C., Thadeio P. F., Lipinski Chr. A., Liston D. R., Spencer R. W., Williams I. H. Physical parameters for brain uptake: optimizing log P, log D and pka of THA. Bioorg. Med. Chem. Lett 1991; 8: 411–414
   Google Scholar
• El Tayar N., Testa B., Carrupt P. A. Polar intermolecular interactions encoded in partition coefficients: An indirect estimation of H-bonding parameters of polyfunc-tional solutes. J. Phys. Chem 1992; 96: 1455–1459
   Web of Science ®Google Scholar
• El Tayar N., Tsai R. S., Testa B., Carrupt P. A., Leo A. Partitioning of solutes in different solvent systems: The contribution of hydrogen-bonding capacity and polarity. J. Pharm. Sci 1991; 80: 590–598
   PubMed Web of Science ®Google Scholar
• Gupta S. P. QSAR studies on drugs acting at the central nervous system. Chem. Rev 1989; 89: 1765–1800
   Web of Science ®Google Scholar
• Hansch C., Björkroth J. P., Leo A. Hydrophobicity and the central nervous system agents: On the principle of minimal hydrophobicity in drug design. J. Pharm. Sci 1987; 76: 663–687
   PubMed Web of Science ®Google Scholar
• Kai J., Nakamura K., Masuda T., Ueda I., Fujiwara H. Thermodynamic aspects of hydrophobicity and the blood-brain barrier permeability studied with a gel filtration chromatography. J. Med. Chem 1996; 39: 2621–2624
   PubMed Web of Science ®Google Scholar
• Kubinyi H. The physicochemical significance of topological parameters. A rebuttal. Quant. Struct. Act. Relat 1995; 14: 149–150
   Google Scholar
• Kulagowski J. J., Baker R., Curtis N. R., Leeson P. D., Mawer I. A., Moseley A. M., Ridgill M. P., Rowley M., Stansfield I., Foster A. C., Grimwood S., Hill R. G., Kemp J. A., Marshall G. R., Saywell K. L., Tricklebank M. D. 3'(Arylmethyi)- and 3'-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: Orally active antagonists of the glycine site of the NMDA receptor. J. Med. Chem 1994; 37: 1402–1405
   PubMed Web of Science ®Google Scholar
• Leo A., Hansch C., Elkins D. Partition coefficients and their uses. Chem. Rev 1971; 71: 525–616
   Web of Science ®Google Scholar
• Levin V. A. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J. Med. Chem 1980; 23: 682–684
   PubMed Web of Science ®Google Scholar
• Leysen J. E., Gommeren W. Optimal conditions for 3H-apomorphine binding and anomalous equilibrium binding of 3H-apomorphine and 3H-spiperone to rat striatal membranes: Involvement of surface phenomena versus multiple binding sites. J. Neurochem 1981; 36: 201–219
   PubMed Web of Science ®Google Scholar
• Lien E. J., Tong G. L., Chou J. T., Lien L. L. Structural requirements for centrally acting drugs I. J. Pharm. Sci 1973; 62: 246–250
   PubMed Web of Science ®Google Scholar
• Lipinski Chr. A., Lombardo F., Dominy B. W., Feeney P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Del. Rev 1997; 23: 3–25
   Web of Science ®Google Scholar
• Lombardo F., Blake J. F., Curatolo W. J. Computation of brain-blood partitioning of organic solutes via free energy calculations. J. Med. Chem 1996; 39: 4750–4755
   PubMed Web of Science ®Google Scholar
• Narawane L., Lee V. H. L. Absorption barriers. Drug Absorption Enhancement, A. G. De Boer. Harwood, Chur 1993; 1–66
   Google Scholar
• N'Goka V., Schlewer G., Linget J. M., Chambon J. P., Wermuth C. G. GABA-uptake inhibitors: construction of a general pharmacophore model and successful prediction of a new representative. J. Med. Chem 1991; 34: 2547–2557
   PubMed Web of Science ®Google Scholar
• Palm K., Luthman K., Ungell A. L., Strandling G., Artursson P. Correlation of drug absorption with molecular surface properties. J. Pharm. Sci 1996; 85: 32–39
   PubMed Web of Science ®Google Scholar
• Palm K., Stenberg P., Luthman K., Arturson P. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm. Res 1997; 14: 568–571
   PubMed Web of Science ®Google Scholar
• Pardridge W. M. Brain drug delivery and blood-brain barrier transport. Drug Deliv 1993; 1: 83–101
   Google Scholar
• Pauletti G. M., Okumu F. W., Borchardt R. T. Effect of size and charge on the passive diffusion of peptides across Caco-2 cell monolayers via the paracellular pathway. Pharm. Res 1997; 14: 164–168
   PubMed Web of Science ®Google Scholar
• Raevsky O. A., Schaper K. J., Seydel J. K. H-bond contribution to octanol-water partition coefficients of polar compounds. Quant. Struct. Act. Relat 1995; 14: 433–436
   Google Scholar
• Raevsky O. A., Grigor'ev V., Kireev D., Zefirov N. Complete thermodynamic description of H-bonding in the framework of multiplicative approach. Quant. Struct. Act. Relat 1992; 11: 49–63
   Google Scholar
• Raevsky O. A. Hydrogen bond strength estimation by means of the HYBOT program package. Computer-Assisted Lead Finding and Optimization, H. Van de Waterbeemd, B. Testa, G. Folkers. Verlag HCA, Basel 1997; 367–378
   Google Scholar
• Schinkel A. H., Wagenaar E., Van Deemter L., Mol C. A. A. M., Borst P. Absence of mdrla P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexa-methasone, digoxin, and cyclosporin A. J. Clin. Invest 1995; 96: 1698–1705
   PubMed Web of Science ®Google Scholar
• Seelig A. Substance P and antagonists. Surface activity and molecular shapes. Biochim. Biophys. Acta 1990; 1030: 111–118
   PubMed Web of Science ®Google Scholar
• Seelig A., Dölz R. Substance P and antagonists. Surface activity, conformations, and lipid binding. Ann. NY Acad. Sci 1991; 632: 468–470
   PubMed Web of Science ®Google Scholar
• Seelig A., Gottschlich R., Devant R. M. A method to determine the ability of drugs to diffuse through the blood-brain barrier. Proc. Natl Acad. Sci. USA 1994; 91: 68–72
   PubMed Web of Science ®Google Scholar
• Ter Laak A. M., Tsai R. S., Donné-Op den Kelder G. M., Carrupt P. A., Testa B. Lipophilicity and hydrogen bonding capacity of H1-antihistaminic agents in relation to their central sedative side-effects. Eur. J. Pharm. Sci 1994; 2: 373–384
   Web of Science ®Google Scholar
• Testa B., Carrupt P. A., Gaillard P., Tsai R. S. Lipophilicity in Drug Action and Toxicology, V. Pliska, B. Testa, H. van de Waterbeemd. VCH, Weinheim 1996; 49–71
   Google Scholar
• Testa B., Seiler P. Steric and lipophobic components of the hydrophobic fragmental constant. Arzneim. Forsch. (Drug Res.) 1981; 31: 1053–1058
   PubMed Web of Science ®Google Scholar
• Tsuji A., Tamai I. Carrier-mediated intestinal transport of drugs. Pharm. Res 1996; 13: 963–977
   PubMed Web of Science ®Google Scholar
• Van Bree J. B. M. M., De Boer A. G., Danhof M., Breimer D. D. Drug transport across the blood-brain barrier. I. Anatomical and physiological aspects. Pharm. Weekbl. Sci. Ed 1992; 14: 305–310
   PubMedGoogle Scholar
• Van de Waterbeemd H. Application of physicochemical methods to oral drug absorption estimation. Eur. J. Pharm. Sci 1997; 5(Suppl. 2)S26–S27
   Google Scholar
• Van de Waterbeemd H., Camenisch G., Folkers G., Raevsky O. A. Estimation of Caco-2 cell permeability using calculated molecular descriptors. Quant. Struct. Act. Relat 1996a; 15: 480–490
   Google Scholar
• Van de Waterbeemd H., Kansy M. Hydrogen-bonding capacity and brain penetration. Chimia 1992; 46: 299–303
   Web of Science ®Google Scholar
• Van de Waterbeemd H., Kansy M., Wagner B., Fischer H. Lipophilicity measurement by reversed-phase high performance liquid chromatography (RP-HPLC). Lipophilicity in Drug Action and Toxicology, V. Pliska, B. Testa, H. Van de Waterbetmd. VCH, Weinheim 1996b; 73–87
   Google Scholar
• Van de Waterbeemd H., Testa B. The parametriza-tion of lipophilicity and other structural properties in drug design. Adv. Drug Res 1987; 16: 85–225
   Google Scholar
• Von Geldern Th. W., Hoffman D. J., Kester J. A., Nellans H. N., Dayton B. D., Calzadilla S. V., Marsch K. C., Hernandez L., Chiou W., Dixon D. B., Wu-Wong J. R., Opgenorth T. J. Azole endothelin antagonists. 3. Using Δ log P as a tool to improve absorption. J. Med. Chem 1996; 39: 982–991
   PubMed Web of Science ®Google Scholar
• Xiang T. X., Anderson B. D. The relationship between permeant size and permeability in lipid bilayer membranes. J. Membr. Biol 1994; 140: 111–122
   PubMed Web of Science ®Google Scholar
• Young R. C., Mitchell R. C., Brown Th. H., Ganellin C. R., Griffiths R., Jones M., Rana K. K., Saunders D., Smith I. R., Sore N. E., Wilks T. J. Development of a new physico-chemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. J. Med. Chem 1988; 31: 656–671
   PubMed Web of Science ®Google Scholar